Systematic Generation of Instruction Test Patterns Based on Architectural Parameters

by Peter Mu, 穆彼得
Published 2001

Using Bioinformatics Tools to Identify New Treatment Strategy for Non Small Cell Lung Cancer

by Peter Mu-Hsin Chang, 張牧新
Published 2013

Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics

by Jiun-I Lai, Jiun-I Lai, Jiun-I Lai, Yu-Jhen Tseng, Ming-Huang Chen, Ming-Huang Chen, Ming-Huang Chen, Chi-Ying F. Huang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang, Peter Mu-Hsin Chang
Published 2020-11-01

Automated genome mining for natural products

by Zajkowski James, Ung Peter MU, Li Michael HT, Garneau-Tsodikova Sylvie, Sherman David H
Published 2009-06-01

AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway

by Wei-Min Chang, Yu-Chan Chang, Yi-Chieh Yang, Sze-Kwan Lin, Peter Mu-Hsin Chang, Michael Hsiao
Published 2019-06-01

Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast c...

by Jia-Hong Chen, Wen-Chien Huang, Oluwaseun Adebayo Bamodu, Peter Mu-Hsin Chang, Tsu-Yi Chao, Tse-Hung Huang
Published 2019-06-01

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

by Chien-Hung Huang, Peter Mu-Hsin Chang, Yong-Jie Lin, Cheng-Hsu Wang, Chi-Ying F. Huang, Ka-Lok Ng
Published 2014-01-01

Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues

by Wu-Hsiung Wu, Fan-Yu Li, Yi-Chen Shu, Jin-Mei Lai, Peter Mu-Hsin Chang, Chi-Ying F. Huang, Feng-Sheng Wang
Published 2020-03-01

Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway

by Tsung-Ching Lai, Chih-Yeu Fang, Yi-Hua Jan, Hsiao-Ling Hsieh, Yi-Fang Yang, Chun-Yu Liu, Peter Mu-Hsin Chang, Michael Hsiao
Published 2020-10-01

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer

by Hsueh-Ju Lu, Chao-Chun Yang, Ling-Wei Wang, Pen-Yuan Chu, Shyh-Kuan Tai, Ming-Huang Chen, Muh-Hwa Yang, Peter Mu-Hsin Chang
Published 2015-01-01

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment

by Ming-Hung Hu, Ling-Wei Wang, Hsueh-Ju Lu, Pen-Yuan Chu, Shyh-Kuan Tai, Tsung-Lun Lee, Ming-Huang Chen, Muh-Hwa Yang, Peter Mu-Hsin Chang
Published 2014-01-01

Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis

by Yu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, Chia-Yi Su, Yuang-Feng Lin, Chi-Long Chen, Ming-Huang Chen, Peter Mu-Hsin Chang, Alex T. H. Wu, Michael Hsiao
Published 2017-01-01

Gene Expression Profiling and Pathway Network Analysis Predicts a Novel Antitumor Function for a Botanical-Derived Drug, PG2

by Yu-Lun Kuo, Chun-Houh Chen, Tsung-Hsien Chuang, Wei-Kai Hua, Wey-Jinq Lin, Wei-Hsiang Hsu, Peter Mu-Hsin Chang, Shih-Lan Hsu, Tse-Hung Huang, Cheng-Yan Kao, Chi-Ying F. Huang
Published 2015-01-01

Transcriptome analysis and prognosis of ALDH isoforms in human cancer

by Peter Mu-Hsin Chang, Che-Hong Chen, Chi-Chun Yeh, Hsueh-Ju Lu, Tze-Tze Liu, Ming-Huang Chen, Chun-Yu Liu, Alexander T. H. Wu, Muh-Hwa Yang, Shyh-Kuan Tai, Daria Mochly-Rosen, Chi-Ying F. Huang
Published 2018-02-01

Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a.

by Hua-Qing Wu, Mei-Ling Cheng, Jin-Mei Lai, Hsuan-Hui Wu, Meng-Chun Chen, Wen-Huan Liu, Wu-Hsiung Wu, Peter Mu-Hsin Chang, Chi-Ying F Huang, Ann-Ping Tsou, Ming-Shi Shiao, Feng-Sheng Wang
Published 2017-07-01

Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma.

by Ming-Huang Chen, Wu-Lung R Yang, Kuan-Ting Lin, Chia-Hung Liu, Yu-Wen Liu, Kai-Wen Huang, Peter Mu-Hsin Chang, Jin-Mei Lai, Chun-Nan Hsu, Kun-Mao Chao, Cheng-Yan Kao, Chi-Ying F Huang
Published 2011-01-01

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway

by Shin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, Yu-Chan Chang, Chiao-En Wu, Dennis Shin-Shian Hsu, Peter Mu-Hsin Chang, Meng-Lun Lu, Chi-Ying F. Huang, Yeu Su, Michael Hsiao, Chun-Nan Yeh, Ming-Huang Chen
Published 2021-07-01

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy

by Shu-Jen Chen, Jen-Hao Cheng, Kien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, Wen-Liang Fang, Yi-Chen Yeh, Yu-Chao Wang, Dennis Shin-Shian Hsu, Chiao-En Wu, Jiun-I Lai, Peter Mu-Hsin Chang, Ming-Han Chen, Meng-Lun Lu, Michael Hsiao, Ming-Huang Chen
Published 2020-06-01

A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors

by Shyh-Jen Wang, Wen-Sheng Huang, Chi-Mu Chuang, Chih-Hsien Chang, Te-Wei Lee, Gann Ting, Ming-Huang Chen, Peter Mu-Hsin Chang, Ta-Chung Chao, Hao-Wei Teng, Yee Chao, Yuh-Min Chen, Tzu-Ping Lin, Ya-Jen Chang, Su-Jung Chen, Yuan-Ruei Huang, Keng-Li Lan
Published 2019-05-01